Combined treatment with exogenous estradiol and progesterone increases the incidence of breast cancer in TA2 mice without ovaries

Cancer Letters

Volumn 311, Issue 2, 2011, Pages 171-176

  Yin, Yu ^a,b   Yang, Zhengduo ^a   Zhang, Shiwu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Mouse mammary tumor virus; Spontaneous breast cancer; Tientsin Albinao 2; Wnt

Indexed keywords

ESTRADIOL; MESSENGER RNA; PROGESTERONE; WNT1 PROTEIN; WNT10B PROTEIN; WNT5A PROTEIN; WNT5B PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE INSERTION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE; OVARIECTOMY; OVARY; PRIORITY JOURNAL; WNT GENE;

ANIMALS; CELL TRANSFORMATION, VIRAL; ESTRADIOL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GONADAL STEROID HORMONES; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; OVARIECTOMY; PROGESTERONE; RETROVIRIDAE INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR VIRUS INFECTIONS; UP-REGULATION; WNT PROTEINS;

MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 80053131754     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.011     Document Type: Article

References (33)

1. Sun B.C., Zhang S.W., Zhang D.F., Liu Y.Q., Li Y., Rong Z., Zhu Y., Jia X.H. Clusterin is associated with spontaneous breast cancer in TA2 mice. FEBS Lett. 2007, 581(17):3277-3282.
2. Sun B.C., Zhang S.W., Zhang D.F., Li Y., Zhao X.L., Luo Y., Guo Y.H. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin, Cancer Res. 2008, 14(21):7050-7059.
3. Wang Y., Jiang J.D., Xu D.P., Li Y., Qu C.F., Holland J.F., Pogo B.G. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer. Cancer Res. 2004, 64(12):4105-4111.
4. Yi L., Wendy P.H., Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer E.V.Harold. Oncogene 2000, 19(8):1002-1009.
5. Ross S.R. MMTV Infectious Cycle and the Contribution of Virus-encoded Proteins to Transformation of Mammary Tissue. J. Mammary Gland Bio. Neoplasia 2008, 13(3):299-307.
6. Ma X.R., Edmund S.U.H., Pauline B., Patricia L., Rahman J. Overexpression of WNT2 and TSG101 genes in colorectal carcinoma. Trop. Biomed. 2008, 25(1):46-57.
7. Etkind P., Du J., Khan A., Pillitteri J., Wiernik P.H. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin. Cancer Res. 2000, 6(4):1273-1278.
8. Mant C., Cason J. A human murine mammary tumour virus-like agent is an unconvincing aetiological agent for human breast cancer. Rev. Med. Virol. 2004, 14:169-177.
9. J Livak K., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408.
10. Ahmedin J., Elizabeth W., Michael J.T. Recent trends in breast cancer incidence rates by age and tumor characteristics among US women. Breast Cancer Res. 2007, 9:R28.
11. Linos E., Spanos D., Rosner B.A., Linos K., Hesketh T., Qu J.D., Gao Y.T., Zheng W., Colditz G.A. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J. Natl. Cancer Inst. 2008, 100(19):1352-1360.
12. Chen X., Zheng Y., Zheng W., Gu K., Chen Z., Lu W., Shu S.O. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta. Oncol. 2009, 27:1-9.
13. Kim K., Zang R., Choi S.C., Ryu S.Y., Kim J.W. Current status of gynecological cancer in China. J. Gynecol. Oncol. 2009, 20(2):72-76.
14. Ford C.E., Tran D., Deng Y., Ta V.T., Rawlinson W.D., Lawson J.S. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin. Cancer Res. 2003, 9:1118-1120.
15. Katz E., Lareef M.H., Rassa J.C., Grande S.M., King L.B., Russo J., Ross S.R., Monroe J.G. MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J. Exp. Med. 2005, 201(3):431-439.
16. Ross S.R., Schmidt J.W., Katz E., Cappelli L., Hultine S., Gimotty P., Monroe J.G. An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors. J. Virol. 2006, 80(18):9000-9008.
17. Mertz J.A., Lozano M.M., Dudley J.P. Rev and Rex proteins of human complex retroviruses function with the MMTV Rem-responsive element. Retrovirology 2009, 6:10-22.
18. Svirshchevskaya E.V., Mariotti J., Wright M.H., Viskova N.Y., Telford W., Fowler D.H., Varticovski L. Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity. BMC Cancer 2008, 8:176-189.
19. Huang S., Chen Y., Podsypanina K., Li Y. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice. Neoplasia 2008, 10(2):118-124.
20. Cho R.W., Wang X., Diehn M., Shedden K., Chen G.Y., Sherlock G., Gurney A., Lewicki J., Clarke M.F. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 2008, 26(2):364-371.
21. Theodorou V., Kimm M.A., Boer M., Wessels L., Theelen W., Jonkers J., Hilkens J. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat. Genet 2007, 39(6):759-769.
22. Brown A.M. Wnt signaling in breast cancer: have we come full circle?. Breast Cancer Res. 2001, 3(6):351-355.
23. He B., You L., Uematsu K., Xu Z., Lee A.Y., Matsangou M., McCormic F., Jablons D.M. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004, 6(1):7-14.
24. Wieczorek M., Paczkowska A., Guzenda P., Majorek M., Bednarek A.K., Lamparska-Przybysz M. Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biol. Ther. 2008, 7(2):268-274.
25. Innes K.E., Byers T.E. First pregnancy characteristics and subsequent breast cancer risk among young women. Int. J. Cancer 2004, 112(2):306-311.
26. Lukanova A., Toniolo P P., Zeleniuch-Jacquotte A., Grankvist K., Wulff M., Arslan A.A., Afanasyeva Y., Johansson R., Lenner P., Hallmans G., Wadell G., Lundin E. Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol. Biomar. Prevent. 2006, 15(12):2489-2493.
27. Hall R.E., Tilley W.D., McPhaul M.J., Sutherland R.L. Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int. J. Cancer 1992, 52(5):778-784.
28. Wang Y., Pelisson I., Melana S.M., Holland J.F., Pogo B.G. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer. Int. J. Oncol. 2001, 18(5):1041-1044.
29. Wu J., Liang Y., Nawaz Z., Hyder S.M., 182 Complex agonist-like properties of ICI 780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance. Int. J. Oncol. 2005, 27(6):1647-1659.
30. Dong Y., Roberge J.Y., Wang Z., Wang X., Tamasi J., Dell V., Golla R., Corte J.R., Liu Y., Fang T., Anthony M.N., Schnur D.M., Agler M.L., Dickson J.K., Lawrence R.M., Prack M.M., Seethala R., Feyen J.H. Characterization of a new class of selective nonsteroidal progesterone receptor agonists. Steroids 2004, 69(3):201-217.
31. Wilson V.S., Bobseine K., Lambright C.R., Gray L.E.J. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicol. Sci. 2002, 66(1):69-81.
32. Nordeen S.K., Kühnel B., Lawler-Heavner J., Barber D.A., Edwards D.P. A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol. Endocrinol. 1989, 3(8):1270-1278.
33. Murphy L.C., Dotzlaw H., Wong M.S., Miller T., Murphy L.J. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Cancer Res. 1991, 51(8):2051-2057.